EN DE
STOCK COMPARISON

Anbio Biotechnology Class A Ordinary Shares vs Intuitive Surgical: Fair Value & Quality

Both stocks run through our valuation models. Here is how Anbio Biotechnology Class A Ordinary Shares (NNNN) and Intuitive Surgical (ISRG) compare, as of Aug 10, 2026.

As of Aug 10, 2026, Fair Value Calculator sees Intuitive Surgical as the less overvalued of the two: Anbio Biotechnology Class A Ordinary Shares trades at $10.61 versus a fair value of $2.70 (-75%), while Intuitive Surgical trades at $379 versus $150 (-60%).
Anbio Biotechnology Class A Ordinary Shares
NNNN · USD · Health Care
-75%
upside to fair value
overvalued
Price$10.61
Fair Value$2.70
Quality68/100
Intuitive Surgical
ISRG · USD · Health Care
-60%
upside to fair value
overvalued
Price$379
Fair Value$150
Quality72/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Anbio Biotechnology Class A Ordinary SharesIntuitive Surgical
Valuation
110.9×P/E (TTM)48.3×
84.46×P/S (TTM)13.35×
24.22×P/B7.92×
—EV/EBITDA35.5×
—PEG2.13×
Profitability
74%Net margin28%
59%Operating margin31%
27%Return on equity17%
15%Return on assets10%
Growth
74%Revenue growth (YoY)23%
-25.4%Avg. growth/yr (3Y)17.4%
—Avg. growth/yr (5Y)18.2%
Balance & size
$730MMarket cap$141B
weakGrowth qualityhealthy

Anbio Biotechnology Class A Ordinary Shares leads: 5 to 4 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Anbio Biotechnology Class A Ordinary Sharesof which business quality 65 · market factors 0 Intuitive Surgicalof which business quality 71 · market factors 22
ProfitabilityMargins and returns on capital today
70
66
Quality GrowthAre margins and returns improving?
76
66
CashflowEarnings quality: real cash, not paper profit
33
79
Fin. StrengthBalance sheet, leverage, solvency risk
97
82
InvestmentDisciplined investing over empire-building
33
37
Low VolatilityCalm price path (market factor)
0
39
MomentumPrice trend over the last 3–12 months (market factor)
0
21
52W MomentumDistance to the 52-week high (market factor)
0
5
Net IssuanceBuybacks instead of dilution
71
80

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Anbio Biotechnology Class A Ordinary Shares

Earnings-Based$3.68
Multiples$2.48
Asset-Based$0.46
Economic Profit$1.52
Growth Earnings$4.97

14 of 14 models see the stock below the current price.

Intuitive Surgical

DCF Models$219
Earnings-Based$160
Dividend Discount$0.40
Multiples$144
Asset-Based$33.72
Growth DCF$185
Economic Profit$105
Growth Earnings$224

25 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Anbio Biotechnology Class A Ordinary Shares
Bear $2.07Fair Value $2.70Bull $3.33
$10.61 = current price (white tick)
Intuitive Surgical
Bear $110Fair Value $150Bull $239
$379 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Anbio Biotechnology Class A Ordinary Shares · Health Care

Quality score68 · Top 25%
Fair value upside-75% · bottom 25%

Intuitive Surgical · Health Care

Quality score72 · Top 25%
Fair value upside-60% · below median

Bottom line

As of Aug 10, 2026, Fair Value Calculator sees Intuitive Surgical as the less overvalued of the two: Anbio Biotechnology Class A Ordinary Shares trades at $10.61 versus a fair value of $2.70 (-75%), while Intuitive Surgical trades at $379 versus $150 (-60%).

Intuitive Surgical has the higher quality score (72/100).

See the full analysis →
Anbio Biotechnology Class A Ordinary Shares · Intuitive Surgical

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Anbio Biotechnology Class A Ordinary Shares

Eli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth GroupUnitedHealth Group vs Merck & Company

Related to Intuitive Surgical

UnitedHealth Group vs AstraZenecaUnitedHealth Group vs Thermo Fisher ScientificUnitedHealth Group vs AmgenUnitedHealth Group vs Abbott Laboratories
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.